ZACKS INVESTMENT MANAGEMENT

Position in NBIX — Neurocrine Biosciences Inc

CIK 1086483 Chicago, IL

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,416,474

-$1,763,560 QoQ

Shares Held

20,271

-60.4% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#248

of 768 holders

Holding Since

Sep 2022

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ZACKS INVESTMENT MANAGEMENT holds $9,127,553 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (37.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	20,271	$3,416,474
2	PAHC	Phibro Animal Health Corp	102,233	$3,210,116
3	COLL	Collegium Pharmaceutical, Inc	52,672	$1,906,726
4	INDV	Indivior Pharmaceuticals, Inc.	14,483	$594,237

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,416,474	20,271	-60.4%	Shares	Sole	2026-08-13
2023-03-31	$5,180,034	51,176	+3.5%	Shares	Sole	2023-05-15
2022-12-31	$5,907,980	49,464	+2.3%	Shares	Sole	2023-02-14
2022-09-30	$5,137,696	48,373	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.